| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M606203200 |
| P698 | PubMed publication ID | 17124180 |
| P2093 | author name string | Pierre-Olivier Estève | |
| Sriharsa Pradhan | |||
| Hang Gyeong Chin | |||
| P2860 | cites work | DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development | Q22010765 |
| O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation | Q24296741 | ||
| A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma | Q24322614 | ||
| Co-operation and communication between the human maintenance and de novo DNA (cytosine-5) methyltransferases | Q24534264 | ||
| Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription | Q24534441 | ||
| The retinoblastoma gene product interacts with maintenance human DNA (cytosine-5) methyltransferase and modulates its activity | Q24536177 | ||
| Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery | Q24562316 | ||
| Targeted mutation of the DNA methyltransferase gene results in embryonic lethality | Q28131773 | ||
| DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters | Q28140428 | ||
| DNA methyltransferase Dnmt1 associates with histone deacetylase activity | Q28141500 | ||
| DNMT1 and DNMT3b cooperate to silence genes in human cancer cells | Q28212826 | ||
| Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway | Q28215330 | ||
| Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor | Q28217975 | ||
| De novo CpG island methylation in human cancer cells | Q28292684 | ||
| Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain | Q28295806 | ||
| Recombinant human DNA (cytosine-5) methyltransferase. I. Expression, purification, and comparison of de novo and maintenance methylation | Q28609169 | ||
| A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells | Q29547557 | ||
| Requirement for p53 and p21 to sustain G2 arrest after DNA damage | Q29547667 | ||
| Partitioning and plasticity of repressive histone methylation states in mammalian chromatin | Q29614513 | ||
| Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif | Q29620290 | ||
| Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity | Q31038912 | ||
| Human maintenance DNA (cytosine-5)-methyltransferase and p53 modulate expression of p53-repressed promoters | Q33732110 | ||
| Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer | Q33952921 | ||
| Mammalian DNA (cytosine-5) methyltransferases and their expression | Q34273147 | ||
| Inhibition of melanoma tumor growth in vivo by survivin targeting | Q34623127 | ||
| The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. | Q34888585 | ||
| Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers | Q35083484 | ||
| Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. | Q35207550 | ||
| Epigenetic changes in colorectal cancer. | Q35682096 | ||
| Chromatin modifying activity of leukaemia associated fusion proteins | Q36088954 | ||
| Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein | Q38300297 | ||
| Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation | Q38345845 | ||
| DNA damage-induced down-regulation of human Cdc25C and Cdc2 is mediated by cooperation between p53 and maintenance DNA (cytosine-5) methyltransferase 1. | Q40261691 | ||
| CpG islands and genes | Q40406688 | ||
| Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis | Q40442787 | ||
| Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. | Q40543122 | ||
| Independent repression of a GC-rich housekeeping gene by Sp1 and MAZ involves the same cis-elements | Q40819762 | ||
| Sp1 is required for the early response of alpha2(I) collagen to transforming growth factor-beta1. | Q41094631 | ||
| Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription | Q41684614 | ||
| GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase | Q41718635 | ||
| Sp1 elements protect a CpG island from de novo methylation | Q42497349 | ||
| The same nuclear proteins bind the proximal CACCC box of the human beta-globin promoter and a similar sequence in the enhancer | Q43571710 | ||
| Transcription from a TATA-less promoter requires a multisubunit TFIID complex | Q46109338 | ||
| Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. | Q50335767 | ||
| Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia. | Q52087420 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2615-2625 | |
| P577 | publication date | 2006-11-22 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells | |
| P478 | volume | 282 |
| Q33748743 | 1,1-Bis(3'-indolyl)-1-(p-bromophenyl)methane and related compounds repress survivin and decrease gamma-radiation-induced survivin in colon and pancreatic cancer cells |
| Q36014055 | 15q12 variants, sputum gene promoter hypermethylation, and lung cancer risk: a GWAS in smokers |
| Q91484672 | A review on arsenic carcinogenesis: Epidemiology, metabolism, genotoxicity and epigenetic changes |
| Q34531308 | A synthetic interaction screen identifies factors selectively required for proliferation and TERT transcription in p53-deficient human cancer cells. |
| Q39704674 | A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer |
| Q37962611 | Aberrant epigenetic grooming of miRNAs in pancreatic cancer: a systems biology perspective |
| Q34478447 | An Emerging Role for Epigenetic Dysregulation in Arsenic Toxicity and Carcinogenesis |
| Q51687450 | Antagonizing canonical Wnt signaling pathway by recombinant human sFRP4 purified from E. coli and its implications in cancer therapy. |
| Q37681199 | Aurora kinase A regulates Survivin stability through targeting FBXL7 in gastric cancer drug resistance and prognosis |
| Q36328934 | Automethylation of G9a and its implication in wider substrate specificity and HP1 binding |
| Q38202821 | DNA methylation and apoptosis resistance in cancer cells |
| Q46161723 | Dietary nutrient intake, ethnicity, and epigenetic silencing of lung cancer genes detected in sputum in New Mexican smokers. |
| Q41922113 | Dnmt1/Transcription factor interactions: an alternative mechanism of DNA methylation inheritance |
| Q36790428 | Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation |
| Q38059387 | Drugging the undruggable: transcription therapy for cancer |
| Q34803710 | EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells |
| Q37145875 | Effect of hypoxia-inducible factor-1alpha on transcription of survivin in non-small cell lung cancer |
| Q39668059 | Enhanced tumor suppression in vitro and in vivo by co-expression of survivin-specific siRNA and wild-type p53 protein |
| Q47215045 | Epigenetic mechanism of survivin dysregulation in human cancer |
| Q40103534 | Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance |
| Q98158991 | Expression of anti-apoptotic protein survivin in human endometrial carcinoma: Clinical and pathological associations as a separate factor and in combination with concomitant PTEN and p53 expression |
| Q33567379 | FoxM1 mediated resistance to gefitinib in non-small-cell lung cancer cells |
| Q35783026 | Functional cooperation between HP1 and DNMT1 mediates gene silencing. |
| Q37181679 | HIF-1α knockdown by miRNA decreases survivin expression and inhibits A549 cell growth in vitro and in vivo |
| Q33974244 | Haplotypes of DNMT1 and DNMT3B are associated with mutagen sensitivity induced by benzo[a]pyrene diol epoxide among smokers |
| Q38395896 | Hypoxic tumor microenvironment in advanced retinoblastoma. |
| Q42588131 | Impact of the DNA methyltransferases expression on the methylation status of apoptosis-associated genes in glioblastoma multiforme. |
| Q38310745 | Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex |
| Q35745202 | Insulin Protects Cardiac Myocytes from Doxorubicin Toxicity by Sp1-Mediated Transactivation of Survivin |
| Q39852047 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation |
| Q49269166 | Mithramycin A suppresses basal triple-negative breast cancer cell survival partially via down-regulating Krüppel-like factor 5 transcription by Sp1. |
| Q34596689 | OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma |
| Q39363440 | Overexpression of DNA polymerase iota (Polι) in esophageal squamous cell carcinoma |
| Q33297459 | Primer extension-based method for the generation of a siRNA/miRNA expression vector |
| Q33862606 | Retracted: Placenta Growth Factor-1 Exerts Time-Dependent Stabilization of Adherens Junctions Following VEGF-Induced Vascular Permeability |
| Q38267908 | Sp1 and the 'hallmarks of cancer'. |
| Q30524654 | Sp1 expression regulates lung tumor progression. |
| Q39571381 | Sp1 upregulates survivin expression in adenocarcinoma of lung cell line A549. |
| Q37056726 | Specific inhibition of one DNMT1-including complex influences tumor initiation and progression. |
| Q89157968 | Targeting Transcription Factors for Cancer Treatment |
| Q38289584 | Targeting specificity protein 1 transcription factor and survivin using tolfenamic acid for inhibiting Ewing sarcoma cell growth. |
| Q28076855 | The Role of the Ubiquitously Expressed Transcription Factor Sp1 in Tissue-specific Transcriptional Regulation and in Disease |
| Q37784574 | The role of Sp1 and Sp3 in normal and cancer cell biology |
| Q35667653 | The role of survivin in diagnosis, prognosis and treatment of breast cancer |
| Q24273295 | The transcription factor p53: not a repressor, solely an activator |
| Q39691784 | Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma |
| Q40092481 | Transcriptional control of human T-BET expression: the role of Sp1. |
| Q38160371 | Transcriptional regulation of the survivin gene |
| Q28576215 | Upregulation of Nox4 in the aging vasculature and its association with smooth muscle cell polyploidy |
| Q35180856 | Wild-type p53 controls cell motility and invasion by dual regulation of MET expression |
| Q38986068 | YM155 reverses rapamycin resistance in renal cancer by decreasing survivin. |
| Q42090504 | p53 Impairs Endothelial Function by Transcriptionally Repressing Kruppel-Like Factor 2 |
| Q33376888 | p53 induces distinct epigenetic states at its direct target promoters |
| Q33794127 | p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes |
Search more.